spot_img

The patent war with Big Pharma


Major pharmaceutical companies have recently locked horns with Indian courts over the issue of patents. India has conformed with international patent regulations, but is negotiating aggressively to defend its own drug industry, which produces excellent generic medicines used in many developing countries.

Major pharmaceutical companies have recently locked horns with Indian courts over the issue of patents. India has conformed with international patent regulations, but is negotiating aggressively to defend its own drug industry, which produces excellent generic medicines used in many developing countries.

India’s Supreme Court has definitively rejected Swiss pharmaceutical giant Novartis AG’s request to recognise the patent on its drug Glivec (known in the US as Gleevec), a medicine widely used in the treatment of leukaemia.

This content if for our subscribers

Subscribe for 1 year and gain unlimited access to all content on eastwest.eu plus both the digital and the hard copy of the geopolitical magazine

Subscribe now €45

Gain 1 year of unlimited access to only the website and digital magazine

Subscribe now €20

- Advertisement -spot_img

Environmental Sustainability Within Private Companies

Environmental Sustainability Within Private Companies

Singapore: Who Is Lawrence Wong

Brazil Suffers From Climate Change

Xi Jinping: The Trip To Europe

rivista di geopolitica, geopolitica e notizie dal mondo